For: | Garcovich M, Zocco MA, Roccarina D, Ponziani FR, Gasbarrini A. Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota. World J Gastroenterol 2012; 18(46): 6693-6700 [PMID: 23239905 DOI: 10.3748/wjg.v18.i46.6693] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i46/6693.htm |
Number | Citing Articles |
1 |
Alba Moratalla, Javier Ampuero, Pablo Bellot, Rocío Gallego‐Durán, Pedro Zapater, Manuela Roger, Blanca Figueruela, Belén Martínez‐Moreno, José M. González‐Navajas, José Such, Manuel Romero‐Gómez, Rubén Francés. Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy. Liver International 2017; 37(2): 212 doi: 10.1111/liv.13200
|
2 |
Gregory P. Donaldson, S. Melanie Lee, Sarkis K. Mazmanian. Gut biogeography of the bacterial microbiota. Nature Reviews Microbiology 2016; 14(1): 20 doi: 10.1038/nrmicro3552
|
3 |
Zeeshan Butt, Nauman A. Jadoon, Osman N. Salaria, Kamran Mushtaq, Irbaz B. Riaz, Ahmed Shahzad, Ali M. Hashmi, Shahid Sarwar. Diabetes mellitus and decompensated cirrhosis: Risk of hepatic encephalopathy in different age groups (糖尿病与失代偿性肝硬化:不同年龄组的肝性脑病风险). Journal of Diabetes 2013; 5(4): 449 doi: 10.1111/1753-0407.12067
|
4 |
Lan-Jing Wang, Xin Yao, Qi Qi, Jian-Ping Qin. Prevention and treatment of hepatic encephalopathy during the perioperative period of transjugular intrahepatic portosystemic shunt. World Journal of Gastrointestinal Surgery 2023; 15(8): 1564-1573 doi: 10.4240/wjgs.v15.i8.1564
Abstract(414) |
Core Tip(400) |
Full Article(HTML)(1406)
|
Full Article with Cover (PDF)-990K(86)
|
Full Article (Word)-127K(56)
|
Audio-1599K(2)
|
Peer-Review Report-317K(56)
|
Answering Reviewers-33K(55)
|
Full Article (PDF)-433K(134)
|
Full Article (XML)-206K(45)
|
Times Cited (1)
|
Total Visits (3536)
|
Open
|
5 |
David W. Victor, Eamonn M.M. Quigley. Hepatic Encephalopathy Involves Interactions Among the Microbiota, Gut, Brain. Clinical Gastroenterology and Hepatology 2014; 12(6): 1009 doi: 10.1016/j.cgh.2014.01.022
|
6 |
Rajan Singh, Hannah Zogg, Lai Wei, Allison Bartlett, Uday C Ghoshal, Singh Rajender, Seungil Ro. Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders. Journal of Neurogastroenterology and Motility 2021; 27(1): 19 doi: 10.5056/jnm20149
|
7 |
Jingjing Li, Zujiang Yu, Qiongye Wang, Duolu Li, Bin Jia, Yubing Zhou, Yanwei Ye, Shen Shen, Yanfang Wang, Shasha Li, Lu Bai, Quancheng Kan. Hyperammonia induces specific liver injury through an intrinsic Ca2+-independent apoptosis pathway. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-151
|
8 |
Pavlo Petakh, Valentyn Oksenych, Iryna Kamyshna, Iryna Boisak, Katerina Lyubomirskaya, Oleksandr Kamyshnyi. Exploring the complex interplay: gut microbiome, stress, and leptospirosis. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1345684
|
9 |
Xiao Wei, Shan Jiang, Xiangna Zhao, Huan Li, Weishi Lin, Boxing Li, Jing Lu, Yansong Sun, Jing Yuan. Community-Metabolome Correlations of Gut Microbiota from Child-Turcotte-Pugh of A and B Patients. Frontiers in Microbiology 2016; 7 doi: 10.3389/fmicb.2016.01856
|
10 |
Philipp Schindler, Leon Seifert, Max Masthoff, Arne Riegel, Michael Köhler, Christian Wilms, Hartmut H. Schmidt, Hauke Heinzow, Moritz Wildgruber. TIPS Modification in the Management of Shunt-Induced Hepatic Encephalopathy: Analysis of Predictive Factors and Outcome with Shunt Modification. Journal of Clinical Medicine 2020; 9(2): 567 doi: 10.3390/jcm9020567
|
11 |
Lauren R. Heinzinger, Angus Johnson, Jenna I. Wurster, Rachael Nilson, Swathi Penumutchu, Peter Belenky. Oxygen and Metabolism: Digesting Determinants of Antibiotic Susceptibility in the Gut. iScience 2020; 23(12): 101875 doi: 10.1016/j.isci.2020.101875
|
12 |
Suraphan Panyod, Wei-Kai Wu, Kuan-Hung Lu, Chun-Ting Liu, Yung-Lin Chu, Chi-Tang Ho, Wen-Luan Wendy Hsiao, Yi-Syuan Lai, Wei-Cheng Chen, Yu-En Lin, Shi-Hang Lin, Ming-Shiang Wu, Lee-Yan Sheen. Allicin Modifies the Composition and Function of the Gut Microbiota in Alcoholic Hepatic Steatosis Mice. Journal of Agricultural and Food Chemistry 2020; 68(10): 3088 doi: 10.1021/acs.jafc.9b07555
|
13 |
J. S. Bajaj. Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis. Alimentary Pharmacology & Therapeutics 2016; 43(S1): 11 doi: 10.1111/apt.13435
|
14 |
Jasmohan S. Bajaj, Giovanni Barbara, Herbert L. DuPont, F. Mearin, Antonio Gasbarrini, Jan Tack. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases. Digestive and Liver Disease 2018; 50(8): 741 doi: 10.1016/j.dld.2018.04.020
|
15 |
Jérémie Jacques, Paul Carrier, Marilyne Debette-Gratien, Rodolphe Sobesky, Véronique Loustaud-Ratti. Encéphalopathie hépatique. La Presse Médicale 2016; 45(1): 46 doi: 10.1016/j.lpm.2015.02.021
|
16 |
Arumugam R. Jayakumar, Xiao Y. Tong, Kevin M. Curtis, Roberto Ruiz‐Cordero, Maria T. Abreu, Michael D. Norenberg. Increased toll‐like receptor 4 in cerebral endothelial cells contributes to the astrocyte swelling and brain edema in acute hepatic encephalopathy. Journal of Neurochemistry 2014; 128(6): 890 doi: 10.1111/jnc.12516
|
17 |
Patricia P. Bloom, Elliot B. Tapper, Vincent B. Young, Anna S. Lok. Microbiome therapeutics for hepatic encephalopathy. Journal of Hepatology 2021; 75(6): 1452 doi: 10.1016/j.jhep.2021.08.004
|
18 |
Felipe Toyama Aires, Paola Teruya Ramos, Wanderley Marques Bernardo. Efficacy of lactulose in the prophylaxis of hepatic encephalopathy in cirrhotic patients presenting gastrointestinal bleeding. Revista da Associação Médica Brasileira 2016; 62(3): 243 doi: 10.1590/1806-9282.62.03.243
|
19 |
Noriaki Naeshiro, Hideaki Kakizawa, Hiroshi Aikata, Hiromi Kan, Hatsue Fujino, Takayuki Fukuhara, Tomoki Kobayashi, Yohji Honda, Daisuke Miyaki, Tomokazu Kawaoka, Masataka Tsuge, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Hideyuki Hyogo, Masaki Ishikawa, Kazuo Awai, Kazuaki Chayama. Percutaneous transvenous embolization for portosystemic shunts associated with encephalopathy: Long‐term outcomes in 14 patients. Hepatology Research 2014; 44(7): 740 doi: 10.1111/hepr.12181
|
20 |
Herbert L. DuPont. Therapeutic Effects and Mechanisms of Action of Rifaximin in Gastrointestinal Diseases. Mayo Clinic Proceedings 2015; 90(8): 1116 doi: 10.1016/j.mayocp.2015.04.016
|
21 |
Sung-Min Won, Eunju Park, Jin-Ju Jeong, Raja Ganesan, Haripriya Gupta, Yoseph Gebru, SatyaPriya Sharma, Dong-Joon Kim, Ki-Tae Suk. The Gut Microbiota-Derived Immune Response in Chronic Liver Disease. International Journal of Molecular Sciences 2021; 22(15): 8309 doi: 10.3390/ijms22158309
|
22 |
Kakulavarapu V. Rama Rao, Arumugam R. Jayakumar, Michael D. Norenberg. Brain edema in acute liver failure: mechanisms and concepts. Metabolic Brain Disease 2014; 29(4): 927 doi: 10.1007/s11011-014-9502-y
|
23 |
Michael W. Rowley, Myunghan Choi, Steve Chen, Kevin Hirsch, Anil B. Seetharam. Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision. CardioVascular and Interventional Radiology 2018; 41(11): 1765 doi: 10.1007/s00270-018-1992-2
|
24 |
Michael W. Rowley, Myunghan Choi, Steve Chen, Kevin Hirsch, Anil B. Seetharam. Race and Gradient Difference Are Associated with Increased Risk of Hepatic Encephalopathy Hospital Admission After Transjugular Intrahepatic Portosystemic Shunt Placement. Journal of Clinical and Experimental Hepatology 2018; 8(3): 256 doi: 10.1016/j.jceh.2017.12.003
|
25 |
Makoto Usami, Makoto Miyoshi, Hayato Yamashita. Gut microbiota and host metabolism in liver cirrhosis. World Journal of Gastroenterology 2015; 21(41): 11597-11608 doi: 10.3748/wjg.v21.i41.11597
|
26 |
Fengfei Sun, Junfeng Chen, Kai Liu, Meizhen Tang, Yuewei Yang. The avian gut microbiota: Diversity, influencing factors, and future directions. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.934272
|
27 |
Andrew G. Taylor, Kanti P. Kolli, Robert K. Kerlan. Techniques for Transjugular Intrahepatic Portosystemic Shunt Reduction and Occlusion. Techniques in Vascular and Interventional Radiology 2016; 19(1): 74 doi: 10.1053/j.tvir.2016.01.008
|
28 |
G. Vassallo, A. Mirijello, A. Ferrulli, M. Antonelli, R. Landolfi, A. Gasbarrini, G. Addolorato. Review article: alcohol and gut microbiota ‐ the possible role of gut microbiota modulation in the treatment of alcoholic liver disease. Alimentary Pharmacology & Therapeutics 2015; 41(10): 917 doi: 10.1111/apt.13164
|
29 |
Eamonn M Quigley, Howard P Monsour. The gut microbiota and the liver: implications for clinical practice. Expert Review of Gastroenterology & Hepatology 2013; 7(8): 723 doi: 10.1586/17474124.2013.848167
|
30 |
Rahul Rai, Vivek A. Saraswat, Radha K. Dhiman. Gut Microbiota: Its Role in Hepatic Encephalopathy. Journal of Clinical and Experimental Hepatology 2015; 5: S29 doi: 10.1016/j.jceh.2014.12.003
|
31 |
Daniela Campion, Ilaria Giovo, Paola Ponzo, Giorgio M Saracco, Federico Balzola, Carlo Alessandria. Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis. World Journal of Hepatology 2019; 11(6): 489-512 doi: 10.4254/wjh.v11.i6.489
|
32 |
Leon Louis Seifert, Philipp Schindler, Martin Schoster, Jan Frederic Weller, Christian Wilms, Hartmut H. Schmidt, Miriam Maschmeier, Max Masthoff, Michael Köhler, Hauke Heinzow, Moritz Wildgruber. Recurrence of Hepatic Encephalopathy after TIPS: Effective Prophylaxis with Combination of Lactulose and Rifaximin. Journal of Clinical Medicine 2021; 10(20): 4763 doi: 10.3390/jcm10204763
|
33 |
Lucia Giuli, Marta Maestri, Francesco Santopaolo, Maurizio Pompili, Francesca Romana Ponziani. Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease. Metabolites 2023; 13(6): 772 doi: 10.3390/metabo13060772
|
34 |
Ming Luo, Jian-Yang Guo, Wu-Kui Cao. Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis. World Journal of Gastroenterology 2015; 21(41): 11815-11824 doi: 10.3748/wjg.v21.i41.11815
|
35 |
Tamalika Chakraborty, Jeenatara Begum, Dipanjan Mandal, Abhijit Sengupta. Advances in Probiotics. 2021; : 203 doi: 10.1016/B978-0-12-822909-5.00013-7
|
36 |
Wei-Wei Wang, Yu Zhang, Xiao-Bing Huang, Nan You, Lu Zheng, Jing Li. Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction. World Journal of Gastroenterology 2017; 23(38): 6983-6994 doi: 10.3748/wjg.v23.i38.6983
|
37 |
Ramzi Hassouneh, Jasmohan S. Bajaj. Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment. Journal of Clinical Medicine 2021; 10(2): 330 doi: 10.3390/jcm10020330
|
38 |
Rohan Dalal, Richard G McGee, Stephen M Riordan, Angela C Webster. Probiotics for people with hepatic encephalopathy. Cochrane Database of Systematic Reviews 2017; 2021(1) doi: 10.1002/14651858.CD008716.pub3
|
39 |
Alberto Nicoletti, Francesca Romana Ponziani, Marco Biolato, Venanzio Valenza, Giuseppe Marrone, Gabriele Sganga, Antonio Gasbarrini, Luca Miele, Antonio Grieco. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. World Journal of Gastroenterology 2019; 25(33): 4814-4834 doi: 10.3748/wjg.v25.i33.4814
|
40 |
Cinzia Signorini, Claudio De Felice, Silvia Leoncini, Thierry Durand, Jean-Marie Galano, Alessio Cortelazzo, Gloria Zollo, Roberto Guerranti, Stefano Gonnelli, Carla Caffarelli, Marcello Rossi, Alessandra Pecorelli, Giuseppe Valacchi, Lucia Ciccoli, Joussef Hayek. Altered erythrocyte membrane fatty acid profile in typical Rett syndrome: Effects of omega-3 polyunsaturated fatty acid supplementation. Prostaglandins, Leukotrienes and Essential Fatty Acids 2014; 91(5): 183 doi: 10.1016/j.plefa.2014.08.002
|
41 |
Leigh C. Casadaban, Ahmad Parvinian, Jeet Minocha, Janesh Lakhoo, Christopher W. Grant, Charles E. Ray, M. Grace Knuttinen, James T. Bui, Ron C. Gaba. Clearing the Confusion over Hepatic Encephalopathy After TIPS Creation: Incidence, Prognostic Factors, and Clinical Outcomes. Digestive Diseases and Sciences 2015; 60(4): 1059 doi: 10.1007/s10620-014-3391-0
|
42 |
Stephen D. H. Malnick, David Fisher, Marina Somin, Manuela G. Neuman. Treating the Metabolic Syndrome by Fecal Transplantation—Current Status. Biology 2021; 10(5): 447 doi: 10.3390/biology10050447
|